Google bio-firm in $1.5B alliance against ills of aging
by
SAN FRANCISCOSep 05, 2014 - 12:00 am GMT+3
by
Sep 05, 2014 12:00 am
Google-backed life sciences firm Calico and bio-pharmaceutical titan AbbVie on Wednesday announced an alliance to invest $1.5 billion (TL 3.24 billion) to find ways to battle age-related diseases. Under the agreement, the companies will combine strengths to discover, develop and bring to market new therapies for illnesses that afflict people as they get old. The list of targets includes neurodegenerative conditions and cancer. The agreement between the companies will lead to the creation of a premier research and development facility in the San Francisco area. AbbVie and Calico will each provide $250 million at the outset, then later fund the venture with an addition $500 million each, according to the terms of the agreement. AbbVie was spun off from Abbott Laboratories last year to focus on developing ways to treat some of the world's most complex and serious diseases. Calico was created by Google with a mission of using advanced technologies to help people live longer, healthier lives.
Keep up to date with what’s happening in Turkey,
it’s region and the world.
You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.